Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9624298 Anti-PD-L1 antibodies and uses thereof

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
November 21, 2012
0
Date of Patent
April 18, 2017
0
Patent Application Number
14360775
0
Patent Citations Received
‌
US Patent 11884724 Anti-PD-L1 antibodies and uses thereof
0
‌
US Patent 11932692 Methods of treating cancer pain by administering a PD-1 inhibitor
0
‌
US Patent 11701357 Treatment of B cell cancers using a combination comprising Btk inhibitors
0
‌
US Patent 11918649 PD-L1-binding molecules comprising Shiga toxin a subunit scaffolds
0
‌
US Patent 12103922 Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer
0
‌
US Patent 11786529 Treatment of indolent or aggressive B-cell lymphomas using a combination comprising BTK inhibitors
‌
US Patent 11801240 Combination therapies and uses thereof
Patent Inventor Names
Mark Cartwright
0
Christel Iffland
0
Horacio G. Nastri
0
Olivier Leger
0
Qi An
0
Sean D. McKenna
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
9624298
0
Patent Primary Examiner
‌
Ilia Ouspenski
0

Find more entities like US Patent 9624298 Anti-PD-L1 antibodies and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo